Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide in Prostate Cancer Prior to Radical Prostatectomy
NCT00421694Phase 3Completed
- Sponsor
- Università degli Studi dell'Aquila
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bicalutamide in prostate cancer (PCa), sponsored by Università degli Studi dell'Aquila. Status: completed.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00421694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421694.